Candel Therapeutics, Inc. Common Stock (CADL)
Candel Therapeutics, Inc. Common Stock
XNAS:CADL
6.23
$6.30 - 1,400.00
$5.67 - 100.00
$6.23
$6.62
$6.28
$6.3
13.68
4.25
846363
891758.5
41059536.54
Chart
TendieTensor AI Analysis
Company
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Fundamentals
38
-11.260000
4.316370
100
BBG00N0D4Z71
BBG00N0D4Z80
54.90M
54.90M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own CADL. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.